A Case of Diffuse Astrocytoma with 32-year Survival after Boron Neutron Capture Therapy-Reference-Cited by-同舟云学术

A Case of Diffuse Astrocytoma with 32-year Survival after Boron Neutron Capture Therapy

Published:2020 Issue:4 Volume:7 Page:211-215
ISSN:2188-4226
Container-title:NMC Case Report Journal
language:en
Short-container-title:

Author:

Kamano Shuji¹,Matsuyama Masayuki¹,Minamimura Kenzo²

Affiliation:

1. Department of Neurosurgery, Inagi Municipal Hospital, Inagi, Tokyo, Japan

2. Department of Neurosurgery, Shinkawabashi Hospital, Kawasaki, Kanagawa, Japan

Publisher

Japan Neurosurgical Society

Subject

Polymers and Plastics,General Environmental Science

Link

https://www.jstage.jst.go.jp/article/nmccrj/7/4/7_cr.2019-0228/_pdf

Reference24 articles.

1. 1) Bauman G, Fisher B, Watling C, Cairncross JG, Macdonald D: Adult supratentorial low-grade glioma: long-term experience at a single institution. Int J Radial Oncol Biol Phys 75(5): 1401–1407, 2009

2. 2) Claus EB, Black PM: Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001. Cancer 106: 1358–1363, 2006

3. 3) Hatanaka H, Amano K, Kamano S, Fankhauser H, Hanamura T, Sano K: Boron-neutron capture therapy in relation to immunotherapy. Acta Neurochir (Wien) 42: 57–72, 1978

4. 4) Hatanaka H, Kamano S, Amano K, Hojo S, Sano K, Egawa S, et al.: Clinical: experience of boron-neutron capture therapy for gliomas. A comparison with conventional chemo-immuno-radiotherapy. In: Hatanaka H, eds. Boron-Neutron Capture Therapy for Tumors. Niigata: Nishimura, 1986; pp 355–362

5. 5) Hatanaka H, Nakagawa Y: Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy. Int J Radiat Oncol Biol Phys 28: 1061–1066, 1994

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of sodium borocaptate (BSH) and boronophenylalanine (BPA) as boron delivery agents for neutron capture therapy (NCT) of cancer: an update and a guide for the future clinical evaluation of new boron delivery agents for NCT;Cancer Communications;2024-07-08